223 related articles for article (PubMed ID: 11190237)
41. [The present sensitivity development of pathological microorganisms].
Roser H
Munch Med Wochenschr; 1969 Mar; 111(12):658-62. PubMed ID: 5819269
[No Abstract] [Full Text] [Related]
42. [Infectiology and tropical medicine 2007].
Löbermann M; Reisinger EC
Dtsch Med Wochenschr; 2007 Jun; 132(25-26):1399-403. PubMed ID: 17570089
[No Abstract] [Full Text] [Related]
43. Global antibiotic resistance and its impact on the dental community.
Pallasch TJ
J Calif Dent Assoc; 2000 Mar; 28(3):215-33. PubMed ID: 11326536
[TBL] [Abstract][Full Text] [Related]
44. Glucocorticoids in infectious diseases.
Effersoe P
Acta Med Scand Suppl; 1969; 500():67-9. PubMed ID: 5270163
[No Abstract] [Full Text] [Related]
45. Perspective from a quarter century of antibiotic usage.
Jackson GG
JAMA; 1974 Feb; 227(6):634-7. PubMed ID: 4405822
[No Abstract] [Full Text] [Related]
46. Protease inhibitors: resistance, resistance, resistance.
Gilden D; Falkenberg J; Torres G
GMHC Treat Issues; 1997 Feb; 11(2):5-10. PubMed ID: 11364108
[TBL] [Abstract][Full Text] [Related]
47. Antimicrobials.
Walsh CT; Wright GD
Curr Opin Microbiol; 2009 Oct; 12(5):473-5. PubMed ID: 19733112
[No Abstract] [Full Text] [Related]
48. Action against antibiotic resistance: no time to lose.
Hawkey PM
Lancet; 1998 May; 351(9112):1298-9. PubMed ID: 9643787
[No Abstract] [Full Text] [Related]
49. Minimizing antimicrobial resistance: the key role of the infectious diseases physician.
McGowan JE
Clin Infect Dis; 2004 Apr; 38(7):939-42. PubMed ID: 15034824
[No Abstract] [Full Text] [Related]
50. [60 years' of antibiotics--resistance: a time bomb for the third millenium].
Blahová J; Králiková K; Krcméry V
Cas Lek Cesk; 2000 Oct; 139(20):615-9. PubMed ID: 11192755
[TBL] [Abstract][Full Text] [Related]
51. Current concepts in HIV pathogenesis and treatment.
Gupta G
J Calif Dent Assoc; 2001 Feb; 29(2):129-35. PubMed ID: 11324112
[TBL] [Abstract][Full Text] [Related]
52. ESCAIDE 2015: an operational scientific conference on infectious diseases for professionals from Europe and beyond.
Sabbatucci M; Jasir A
Euro Surveill; 2016; 21(11):30166. PubMed ID: 27020459
[No Abstract] [Full Text] [Related]
53. The rising impact of mathematical modelling in epidemiology: antibiotic resistance research as a case study.
Temime L; Hejblum G; Setbon M; Valleron AJ
Epidemiol Infect; 2008 Mar; 136(3):289-98. PubMed ID: 17767792
[TBL] [Abstract][Full Text] [Related]
54. [Resistance in HIV therapy. Which cases profit from resistance testing].
Manegold C
MMW Fortschr Med; 2001 Apr; 143 Suppl 1():26-30. PubMed ID: 11373772
[TBL] [Abstract][Full Text] [Related]
55. Resistance test welcomed, with caution.
AIDS Alert; 1997 Oct; 12(10):113-5. PubMed ID: 11364716
[TBL] [Abstract][Full Text] [Related]
56. [20 years of antibiotics in the treatment of infectious diseases].
Therapiewoche; 1965 Sep; 15(18):975-9. PubMed ID: 5840228
[No Abstract] [Full Text] [Related]
57. [Pediatric infectious diseases--an ongoing battle].
Spirer Z; Barzilai A
Harefuah; 2012 Aug; 151(8):447-9, 499. PubMed ID: 23350286
[TBL] [Abstract][Full Text] [Related]
58. HIV resistance: the new enemy.
Colvin R
Common Factor; 1997 Nov; (No 11):6-7. PubMed ID: 11364845
[TBL] [Abstract][Full Text] [Related]
59. Stepping up to the plate.
Nat Immunol; 2008 Jan; 9(1):1. PubMed ID: 18087245
[No Abstract] [Full Text] [Related]
60. [What is new in infectology?].
Kern WV; Weiss G
Dtsch Med Wochenschr; 2008 Feb; 133(8):339. PubMed ID: 18270912
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
